Iranian Red Crescent Medical Journal

Published by: Kowsar

The Prevalence of Thyroid Dysfunction in Patients With Systemic Lupus Erythematosus

Nakisa Rasaei 1 , Mesbah Shams 2 , Eskandar Kamali-Sarvestani 3 and Mohammad Ali Nazarinia 4 , *
Authors Information
1 Internal Medicine Ward, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Endocrine and Metabolism Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
3 Autoimmune Disease Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
4 Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: December 01, 2015, 17 (12); e17298
  • Published Online: December 5, 2015
  • Article Type: Research Article
  • Received: February 1, 2014
  • Revised: July 20, 2015
  • Accepted: August 12, 2015
  • DOI: 10.5812/ircmj.17298

To Cite: Rasaei N, Shams M, Kamali-Sarvestani E, Nazarinia M A. The Prevalence of Thyroid Dysfunction in Patients With Systemic Lupus Erythematosus, Iran Red Crescent Med J. 2015 ; 17(12):e17298. doi: 10.5812/ircmj.17298.

Abstract
Copyright © 2015, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Mosca M, Bombardieri S. Disease-specific quality indicators, guidelines, and outcome measures in systemic lupus erythematosus (SLE). Clin Exp Rheumatol. 2007; 25(6 Suppl 47): 107-13[PubMed]
  • 2. Griffiths B, Mosca M, Gordon C. Assessment of patients with systemic lupus erythematosus and the use of lupus disease activity indices. Best Pract Res Clin Rheumatol. 2005; 19(5): 685-708[DOI][PubMed]
  • 3. Tektonidou MG, Anapliotou M, Vlachoyiannopoulos P, Moutsopoulos HM. Presence of systemic autoimmune disorders in patients with autoimmune thyroid diseases. Ann Rheum Dis. 2004; 63(9): 1159-61[DOI][PubMed]
  • 4. Delamere JP, Scott DL, Felix-Davies DD. Autoimmune thyroiditis. J R Soc Med. 2008; : 102-6
  • 5. Goh KL, Wang F. Thyroid disorders in systemic lupus erythematosus. . Ann Rheum Dis. 1986; 45(7): 579-83
  • 6. Konstadoulakis MM, Kroubouzos G, Tosca A, Piperingos G, Marafelia P, Konstadoulakis M, et al. Thyroid autoantibodies in the subsets of lupus erythematosus: correlation with other autoantibodies and thyroid function. Thyroidology. 1993; 5(1): 1-7[PubMed]
  • 7. Chan AT, Al-Saffar Z, Bucknall RC. Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2001; 40(3): 353-4[PubMed]
  • 8. Pyne D, Isenberg DA. Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis. 2002; 61(1): 70-2[PubMed]
  • 9. Mader R, Mishail S, Adawi M, Lavi I, Luboshitzky R. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol. 2007; 26(11): 1891-4[DOI][PubMed]
  • 10. Antonelli A, Fallahi P, Mosca M, Ferrari SM, Ruffilli I, Corti A, et al. Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism. 2010; 59(6): 896-900[DOI][PubMed]
  • 11. Appenzeller S, Pallone AT, Natalin RA, Costallat LT. Prevalence of thyroid dysfunction in systemic lupus erythematosus. J Clin Rheumatol. 2009; 15(3): 117-9[DOI][PubMed]
  • 12. Al-Awadhi AM, Olusi S, Hasan EA, Abdullah A. Frequency of abnormal thyroid function tests in Kuwaiti Arabs with autoimmune diseases. Med Princ Pract. 2008; 17(1): 61-5[DOI][PubMed]
  • 13. Weetman AP, Walport MJ. The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol. 1987; 26(5): 359-61[PubMed]
  • 14. Smith EL, Shmerling RH. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus. 1999; 8(8): 586-95[PubMed]
  • 15. Hahn BH, Fauci AS, Braunwald Ek DL, Hauser SL, Longo DL, Harrison's Principals of Internal Medicine. 2008; : 2075-83
  • 16. Mills JA. Systemic lupus erythematosus. N Engl J Med. 1994; 330(26): 1871-9[DOI][PubMed]
  • 17. Pisetsky DS. Systemic lupus erythematosus. Med Clin North Am. 1986; 70(2): 337-53
  • 18. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003; 349(16): 1526-33[DOI][PubMed]
  • 19. Lin WY, Chang CL, Fu LS, Lin CH, Lin HK. Systemic lupus erythematosus and thyroid disease: A 10-year study. J Microbiol Immunol Infect. 2014; [DOI][PubMed]
  • 20. Pan XF, Gu JQ, Shan ZY. Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis. PLoS One. 2015; 10(4)[DOI][PubMed]
  • 21. Biro E, Szekanecz Z, Czirjak L, Danko K, Kiss E, Szabo NA, et al. Association of systemic and thyroid autoimmune diseases. Clin Rheumatol. 2006; 25(2): 240-5[DOI][PubMed]
  • 22. Vianna JL, Haga HJ, Asherson RA, Swana G, Hughes GR. A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol. 1991; 18(8): 1193-5[PubMed]
  • 23. Kausman D, Isenberg DA. Thyroid autoimmunity in systemic lupus erythematosus: the clinical significance of a fluctuating course. Br J Rheumatol. 1995; 34(4): 361-4[PubMed]
  • 24. Park DJ, Cho CS, Lee SH, Park SH, Kim HY. Thyroid disorders in Korean patients with systemic lupus erythematosus. Scand J Rheumatol. 1995; 24(1): 13-7[PubMed]
  • 25. Yoshida H, Amino N, Yagawa K, Uemura K, Satoh M, Miyai K, et al. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases. J Clin Endocrinol Metab. 1978; 46(6): 859-62[DOI][PubMed]
  • 26. Groves CJ, Howells RD, Williams S, Darke C, Parkes AB. Primary standardization for the ELISA of serum thyroperoxidase and thyroglobulin antibodies and their prevalence in a normal Welsh population. J Clin Lab Immunol. 1990; 32(3): 147-51[PubMed]
  • 27. Miller FW, Moore GF, Weintraub BD, Steinberg AD. Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum. 1987; 30(10): 1124-31[PubMed]
  • 28. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995; 43(1): 55-68[PubMed]
  • 29. Hrycek A, Hrycek E, Kopczynski P, Kopczynska M, Romanowski L, Walawska A. [The thyroid functional tests, antithyroid antibodies and the level of prolactin in treated patients with systemic lupus erythematosus]. Pol Merkur Lekarski. 2010; 29(172): 231-4[PubMed]
  • 30. Kumar K, Kole AK, Karmakar PS, Ghosh A. The spectrum of thyroid disorders in systemic lupus erythematosus. Rheumatol Int. 2012; 32(1): 73-8[DOI][PubMed]
  • 31. Franco J, Amaya-Amaya J, Molano-Gonzalez N, Caro-Moreno J, Rodriguez-Jimenez M, Acosta-Ampudia Y, et al. Autoimmune thyroid disease in Colombian patients with systemic lupus erythematosus. Clin Endocrinol (Oxf). 2014; [DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments